Je‐Jung Lee

9.5k total citations
330 papers, 4.5k citations indexed

About

Je‐Jung Lee is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Je‐Jung Lee has authored 330 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Hematology, 130 papers in Oncology and 113 papers in Immunology. Recurrent topics in Je‐Jung Lee's work include Multiple Myeloma Research and Treatments (114 papers), Immunotherapy and Immune Responses (77 papers) and Immune Cell Function and Interaction (61 papers). Je‐Jung Lee is often cited by papers focused on Multiple Myeloma Research and Treatments (114 papers), Immunotherapy and Immune Responses (77 papers) and Immune Cell Function and Interaction (61 papers). Je‐Jung Lee collaborates with scholars based in South Korea, United States and Canada. Je‐Jung Lee's co-authors include Hyeoung‐Joon Kim, Sung‐Hoon Jung, Jae‐Sook Ahn, Deok‐Hwan Yang, Deok‐Hwan Yang, Yeo‐Kyeoung Kim, Manh-Cuong Vo, Ik‐Joo Chung, Duck Cho and Paweł Kaliński and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Je‐Jung Lee

315 papers receiving 4.4k citations

Peers

Je‐Jung Lee
John Gibson Australia
Stephen Devereux United Kingdom
Roshini S. Abraham United States
Je‐Jung Lee
Citations per year, relative to Je‐Jung Lee Je‐Jung Lee (= 1×) peers Vito Racanelli

Countries citing papers authored by Je‐Jung Lee

Since Specialization
Citations

This map shows the geographic impact of Je‐Jung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Je‐Jung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Je‐Jung Lee more than expected).

Fields of papers citing papers by Je‐Jung Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Je‐Jung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Je‐Jung Lee. The network helps show where Je‐Jung Lee may publish in the future.

Co-authorship network of co-authors of Je‐Jung Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Je‐Jung Lee. A scholar is included among the top collaborators of Je‐Jung Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Je‐Jung Lee. Je‐Jung Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vo, Manh-Cuong, Mihee Kim, Ga‐Young Song, et al.. (2025). Expanded and activated marrow-infiltrating lymphocytes exhibit potent antimyeloma activity against autologous multiple myeloma cells. Translational Oncology. 60. 102475–102475. 1 indexed citations
2.
Song, Ga‐Young, Seo-Yeon Ahn, Sung‐Hoon Jung, et al.. (2025). Prognostic Value of 18F-FDG PET in Primary Central Nervous System Lymphoma. Clinical Nuclear Medicine. 50(4). 281–288. 1 indexed citations
3.
4.
Vo, Manh-Cuong, Seo-Yeon Ahn, Mihee Kim, et al.. (2022). Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma. Translational Oncology. 20. 101413–101413. 6 indexed citations
5.
Jung, Sung‐Hoon, Kihyun Kım, Sang Eun Yoon, et al.. (2022). Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party. Blood Cancer Journal. 12(11). 157–157. 6 indexed citations
6.
Vo, Manh-Cuong, Jin Young Kim, Chulhong Kim, et al.. (2021). Pilot Study: Quantitative Photoacoustic Evaluation of Peripheral Vascular Dynamics Induced by Carfilzomib In Vivo. Sensors. 21(3). 836–836. 5 indexed citations
7.
Cho, Hee Jeong, Dong Won Baek, Ju-Hyung Kim, et al.. (2021). Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline. Clinical Lymphoma Myeloma & Leukemia. 22(2). 113–120. 1 indexed citations
8.
Jo, Jae‐Cheol, Yoo Jin Lee, Sang Eun Yoon, et al.. (2021). Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT. Blood Cancer Journal. 11(12). 190–190. 14 indexed citations
9.
Kim, Young Seob, Sung‐Eun Lee, Manh-Cuong Vo, et al.. (2019). A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine. Journal for ImmunoTherapy of Cancer. 7(1). 60–60. 41 indexed citations
10.
Kim, Tae‐Hyung, Joon Ho Moon, Jae-Sook Ahn, et al.. (2018). Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse. Blood. 132(15). 1604–1613. 77 indexed citations
11.
Kim, Young Seob, In Duk Jung, Hee Dong Han, et al.. (2018). A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells. OncoImmunology. 7(10). e1472187–e1472187. 16 indexed citations
12.
13.
14.
Jung, Sung‐Hoon, Jae‐Sook Ahn, Yeo-Kyeoung Kim, et al.. (2016). Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients. Journal of Korean Medical Science. 31(7). 1160–1160. 7 indexed citations
15.
Lee, Je‐Jung, et al.. (2010). Usefulness Assessment of VRS for Topographic Surveying. Journal of the Korean Association of Geographic Information Studies. 13(2). 21–28. 1 indexed citations
16.
Muthuswamy, Ravikumar, Julie Urban, Je‐Jung Lee, et al.. (2008). Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation. Cancer Research. 68(14). 5972–5978. 129 indexed citations
17.
Lee, Jin-Sol, Duck Cho, Myung‐Geun Shin, et al.. (2006). Comparison of Amicus and CS-3000 Plus for the Collection of Peripheral Blood Stem Cells. The Korean Journal of Blood Transfusion. 17(1). 39–47. 2 indexed citations
18.
Lee, Il-Kwon, Jeong‐Hwa Choi, Hee Nam Kim, et al.. (2006). Association of cis-Acting rs530 of the ETS2 Transcriptional Factor Gene with High-Risk Acute Myelogenous Leukemia (AML) and Allelic Expression Imbalance Assessment.. Blood. 108(11). 2230–2230. 1 indexed citations
19.
Lee, Je‐Jung, Yeo-Kyeoung Kim, Sang‐Hee Cho, et al.. (2004). Hemolytic Anemia as a Sequela of Arsenic Intoxication Following Long-Term Ingestion of Traditional Chinese Medicine. Journal of Korean Medical Science. 19(1). 127–127. 28 indexed citations
20.
Lee, Je‐Jung, Yeo‐Kyeoung Kim, Sanghee Cho, et al.. (2003). Granulocyte transfusions from G-CSF- and dexamethasone-stimulated healthy donors for treatment of patients with severe neutropenia-related infections. The Korean Journal of Internal Medicine. 64(4). 459–467. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026